1. Home
  2. VNDA vs AXGN Comparison

VNDA vs AXGN Comparison

Compare VNDA & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • AXGN
  • Stock Information
  • Founded
  • VNDA N/A
  • AXGN N/A
  • Country
  • VNDA United States
  • AXGN United States
  • Employees
  • VNDA N/A
  • AXGN N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VNDA Health Care
  • AXGN Health Care
  • Exchange
  • VNDA Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • VNDA 362.6M
  • AXGN 290.2M
  • IPO Year
  • VNDA 2006
  • AXGN N/A
  • Fundamental
  • Price
  • VNDA $6.07
  • AXGN $8.97
  • Analyst Decision
  • VNDA Buy
  • AXGN Strong Buy
  • Analyst Count
  • VNDA 1
  • AXGN 5
  • Target Price
  • VNDA $11.00
  • AXGN $13.00
  • AVG Volume (30 Days)
  • VNDA 955.3K
  • AXGN 391.1K
  • Earning Date
  • VNDA 07-29-2024
  • AXGN 08-05-2024
  • Dividend Yield
  • VNDA N/A
  • AXGN N/A
  • EPS Growth
  • VNDA N/A
  • AXGN N/A
  • EPS
  • VNDA N/A
  • AXGN N/A
  • Revenue
  • VNDA $177,604,000.00
  • AXGN $163,726,000.00
  • Revenue This Year
  • VNDA $2.98
  • AXGN $14.73
  • Revenue Next Year
  • VNDA $19.49
  • AXGN $12.98
  • P/E Ratio
  • VNDA N/A
  • AXGN N/A
  • Revenue Growth
  • VNDA N/A
  • AXGN 13.51
  • 52 Week Low
  • VNDA $3.30
  • AXGN $3.45
  • 52 Week High
  • VNDA $6.75
  • AXGN $10.83
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 57.74
  • AXGN 66.91
  • Support Level
  • VNDA $5.75
  • AXGN $8.17
  • Resistance Level
  • VNDA $5.39
  • AXGN $7.78
  • Average True Range (ATR)
  • VNDA 0.27
  • AXGN 0.46
  • MACD
  • VNDA 0.05
  • AXGN 0.15
  • Stochastic Oscillator
  • VNDA 78.99
  • AXGN 76.73

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: